NSAIDs and peptic ulcers.
出版信息
BMJ. 1990 Mar 24;300(6727):814-6.
Abstract
摘要
相似文献
1
NSAIDs and peptic ulcers.非甾体抗炎药与消化性溃疡
BMJ. 1990 Mar 24;300(6727):814-6.
2
Famotidine to prevent peptic ulcer caused by NSAIDs.
N Engl J Med. 1996 Oct 24;335(17):1322; author reply 1322-3.
3
[Prevention and therapy of NSAID-induced ulcers: fact versus myth].[非甾体抗炎药所致溃疡的预防与治疗：事实与误区]
Schweiz Med Wochenschr. 1996 Sep 14;126(37):1569-72.
4
[How to reduce the risks of NSAIDs].
MMW Fortschr Med. 2008 Jul 31;150(28-31):50-3; quiz 54.
5
NSAIDs and peptic ulcer.非甾体抗炎药与消化性溃疡
N Z Med J. 1992 Jul 22;105(938):298.
6
Preventing NSAID-induced ulcers: the use of misoprostol.
Nurse Pract. 1990 Oct;15(10):38-9, 42.
7
Comparison of the effects of diclofenac or other non-steroidal anti-inflammatory drugs (NSAIDs) and diclofenac or other NSAIDs in combination with proton pump inhibitors (PPI) on hospitalisation due to peptic ulcer disease.双氯芬酸或其他非甾体抗炎药（NSAIDs）以及双氯芬酸或其他NSAIDs与质子泵抑制剂（PPI）联合使用对因消化性溃疡疾病住院的影响比较。
Pharmacoepidemiol Drug Saf. 2007 Aug;16(8):854-8. doi: 10.1002/pds.1387.
8
Prevention of NSAID-induced ulcers.非甾体抗炎药所致溃疡的预防
J Fam Pract. 1996 Sep;43(3):239-40.
9
Misoprostol vs omeprazole for ulcers associated with NSAIDs.米索前列醇与奥美拉唑治疗非甾体抗炎药相关性溃疡的比较
Can Fam Physician. 1998 Nov;44:2371-2.
10
[Prevention of gastroduodenal disorders due to non-steroidal anti-inflammatory drugs].
Ned Tijdschr Geneeskd. 1991 Apr 20;135(16):723-4.
引用本文的文献
1
Hypouricemic and arthritis relapse-reducing effects of compound tufuling oral-liquid in intercritical and chronic gout: A double-blind, placebo-controlled, multicenter randomized trial.复方土茯苓口服液对发作间期及慢性痛风的降尿酸和减少关节炎复发作用：一项双盲、安慰剂对照、多中心随机试验
Medicine (Baltimore). 2017 Mar;96(11):e6315. doi: 10.1097/MD.0000000000006315.
本文引用的文献
1
A prospective endoscopic study of the effect of Orudis and Oruvail on the upper gastrointestinal tract, in patients with osteoarthritis.
Br J Rheumatol. 1988 Apr;27(2):106-9. doi: 10.1093/rheumatology/27.2.106.
2
Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine.预防非甾体抗炎药所致胃十二指肠损伤：雷尼替丁对照试验
BMJ. 1988 Oct 22;297(6655):1017-21. doi: 10.1136/bmj.297.6655.1017.
3
Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum.
Gastroenterology. 1988 Aug;95(2):289-94. doi: 10.1016/0016-5085(88)90482-9.
4
Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial.米索前列醇预防非甾体抗炎药引起的胃溃疡：多中心、双盲、安慰剂对照试验。
Lancet. 1988 Dec 3;2(8623):1277-80. doi: 10.1016/s0140-6736(88)92892-9.
5
Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer.非甾体抗炎药与出血性消化性溃疡
Lancet. 1986 Mar 1;1(8479):462-4. doi: 10.1016/s0140-6736(86)92927-2.
6
Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs.
Dig Dis Sci. 1989 Mar;34(3):424-8. doi: 10.1007/BF01536266.
7
8
A double-blind placebo-controlled comparison of the efficacy and safety of 50, 100, and 200 micrograms of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms.一项双盲安慰剂对照研究，比较每日四次服用50、100和200微克米索前列醇在预防布洛芬引起的胃和十二指肠黏膜损伤及症状方面的疗效和安全性。
Am J Gastroenterol. 1989 Jun;84(6):633-6.
9
Non-steroidal anti-inflammatory drugs and peptic ulcers.非甾体抗炎药与消化性溃疡
BMJ. 1990 Feb 3;300(6720):278-84. doi: 10.1136/bmj.300.6720.278.
Zotero 插件